More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

DCAT Value Chain Insights

Looking at the first quarter of 2014, there have been several noteworthy deals and activity among contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs). The key deal thus far in 2014 is the...
DCAT Value Chain Insights

Global and US venture-capital funding is up in the first quarter and the number of global and US IPOs increases year over year. Financing into the global and US biotech sector is an important barometer of the health of that sector and is an...
DCAT Value Chain Insights

Facing a need to realize $2.0 billion in cost savings, Teva Pharmaceutical Industries Ltd. turns to Procurement to contribute to that goal as the company begins the process to organize its Global Procurement function. For pharmaceutical companies...